Cargando…

Immunological considerations for COVID-19 vaccine strategies

The coronavirus disease 2019 (COVID-19) pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the most formidable challenge to humanity in a century. It is widely believed that prepandemic normalcy will never return until a safe and effective vaccine strategy becomes ava...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeyanathan, Mangalakumari, Afkhami, Sam, Smaill, Fiona, Miller, Matthew S., Lichty, Brian D., Xing, Zhou
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7472682/ https://www.ncbi.nlm.nih.gov/pubmed/32887954 http://dx.doi.org/10.1038/s41577-020-00434-6

Ejemplares similares

COVID‐19: Current knowledge in clinical features, immunological responses, and vaccine development
por: Singh, Ramandeep, et al.
Publicado: (2021)

Adenoviral-vectored next-generation respiratory mucosal vaccines against COVID-19
por: Afkhami, Sam, et al.
Publicado: (2023)

Mucosal immunity and novel tuberculosis vaccine strategies: route of immunisation-determined T-cell homing to restricted lung mucosal compartments
por: Lai, Rocky, et al.
Publicado: (2015)

Advancing Immunotherapeutic Vaccine Strategies Against Pulmonary Tuberculosis
por: Afkhami, Sam, et al.
Publicado: (2020)

Differential Biodistribution of Adenoviral-Vectored Vaccine Following Intranasal and Endotracheal Deliveries Leads to Different Immune Outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2022)

Corrigendum: Differential biodistribution of adenoviral-vectored vaccine following intranasal and endotracheal deliveries leads to different immune outcomes
por: Jeyanathan, Vidthiya, et al.
Publicado: (2023)

Expression and role of VLA-1 in resident memory CD8 T cell responses to respiratory mucosal viral-vectored immunization against tuberculosis
por: Haddadi, Siamak, et al.
Publicado: (2017)

Age at Mycobacterium bovis BCG Priming Has Limited Impact on Anti-Tuberculosis Immunity Boosted by Respiratory Mucosal AdHu5Ag85A Immunization in a Murine Model
por: Damjanovic, Daniela, et al.
Publicado: (2015)

Spray dried VSV-vectored vaccine is thermally stable and immunologically active in vivo
por: Toniolo, Steven P., et al.
Publicado: (2020)

Aerosol delivery, but not intramuscular injection, of adenovirus-vectored tuberculosis vaccine induces respiratory-mucosal immunity in humans
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2022)

Mucosal-Pull Induction of Lung-Resident Memory CD8 T Cells in Parenteral TB Vaccine-Primed Hosts Requires Cognate Antigens and CD4 T Cells
por: Haddadi, Siamak, et al.
Publicado: (2019)

Respiratory mucosal delivery of next-generation COVID-19 vaccine provides robust protection against both ancestral and variant strains of SARS-CoV-2
por: Afkhami, Sam, et al.
Publicado: (2022)

Design Considerations for Intratracheal Delivery Devices to Achieve Proof-of-Concept Dry Powder Biopharmaceutical Delivery in Mice
por: Manser, Myla, et al.
Publicado: (2023)

Subcutaneous BCG vaccination protects against streptococcal pneumonia via regulating innate immune responses in the lung
por: Kang, Alisha, et al.
Publicado: (2023)

Within the Enemy’s Camp: contribution of the granuloma to the dissemination, persistence and transmission of Mycobacterium tuberculosis
por: Shaler, Christopher R., et al.
Publicado: (2013)

Regulation of TB Vaccine-Induced Airway Luminal T Cells by Respiratory Exposure to Endotoxin
por: Chen, Xuerong, et al.
Publicado: (2012)

Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut–lung axis
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2022)

Author Correction: Parenteral BCG vaccine induces lung-resident memory macrophages and trained immunity via the gut–lung axis
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2023)

Intranasal multivalent adenoviral-vectored vaccine protects against replicating and dormant M.tb in conventional and humanized mice
por: Afkhami, Sam, et al.
Publicado: (2023)

AdHu5Ag85A Respiratory Mucosal Boost Immunization Enhances Protection against Pulmonary Tuberculosis in BCG-Primed Non-Human Primates
por: Jeyanathan, Mangalakumari, et al.
Publicado: (2015)

The Immunological Therapeutic Strategies for Controlling Multiple Sclerosis: Considerations during the COVID-19 Pandemic
por: Azimzadeh, Maryam, et al.
Publicado: (2021)

Strategies and safety considerations of booster vaccination in COVID-19
por: Meng, Hanyan, et al.
Publicado: (2022)

Immunological considerations for laboratory staff and COVID-19 biosafety
por: Kintossou, Ambroise Kouame, et al.
Publicado: (2023)

Protocol for isolation and characterization of lung tissue resident memory T cells and airway trained innate immunity after intranasal vaccination in mice
por: D’Agostino, Michael R., et al.
Publicado: (2022)

Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens
por: Afkhami, Sam, et al.
Publicado: (2016)

Considerations for vaccinating children against COVID-19
por: Hart, John D, et al.
Publicado: (2023)

COVID-19: should oral vaccination strategies be given more consideration?
por: Mehan, Aman, et al.
Publicado: (2020)

Immunological Considerations for Schistosoma Vaccine Development: Transitioning to Endemic Settings
por: Driciru, Emmanuella, et al.
Publicado: (2021)

Continuous and Discontinuous Cigarette Smoke Exposure Differentially Affects Protective Th1 Immunity against Pulmonary Tuberculosis
por: Shaler, Christopher R., et al.
Publicado: (2013)

Considerations on COVID-19 vaccination
por: La Cava, Antonio
Publicado: (2023)

Heterologous Boosting of Recombinant Adenoviral Prime Immunization With a Novel Vesicular Stomatitis Virus–vectored Tuberculosis Vaccine
por: Roediger, Elizabeth K, et al.
Publicado: (2008)

Immunological strategies against spike protein: Neutralizing antibodies and vaccine development for COVID‐19
por: Huang, Jiansheng, et al.
Publicado: (2020)

492. Canadian consensus of COVID-19 policy and management aspects
por: Tsang, Kara, et al.
Publicado: (2020)

Medico‐legal considerations of mandatory COVID‐19 vaccination for high risk workers
por: Kevat, Dev AS, et al.
Publicado: (2021)

Limb Regeneration in Amphibians: Immunological Considerations
por: Mescher, Anthony L., et al.
Publicado: (2006)

Immunological and Toxicological Considerations for the Design of Liposomes
por: Inglut, Collin T., et al.
Publicado: (2020)

COVID-19 vaccines: Current evidence and considerations
por: Tavilani, Alireza, et al.
Publicado: (2021)

To aspirate or not to aspirate? Considerations for the COVID-19 vaccines
por: Rzymski, Piotr, et al.
Publicado: (2022)

Vaccine Considerations for Multiple Sclerosis in the COVID-19 Era
por: Coyle, Patricia K., et al.
Publicado: (2021)

Review of Immunologic Manifestations of COVID-19 Infection and Vaccination
por: Pozdnyakova, Valeriya, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_du3r74ideee7tdavmslggv72rh